The trademark Ailomics was filed by Ailomics Therapeutics Co.,Ltd., a corporation established under the laws of the People's Republic of China (the "Applicant"). The application was published for oppositions on November 30, 2022, and received one opposition filed on February 23, 2023 by ZAMBON S.p.A. on Likelihood of confusion. the opponent was represented by Herbert Smith Freehills Studio Legale and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued February 23, 2023
The application was filed in English, and English was also language of all opposition proceedings (Spanish was selected as the second language).
Change of name and professional address of the trademark registration was recorded on November 6, 2023. Change of name and professional address of the trademark registration was recorded on January 22, 2024. Change of name and professional address of the trademark registration was recorded on January 25, 2024.
Goods And Services
The mark was filed in class 5 with following description of goods:
Medicines for human purposes
Drugs for medical purposes
Radioactive substances for medical purposes
Diagnostic biomarker reagents for medical purposes
Bacteriological culture mediums
Dietetic substances adapted for medical use
Depuratives
Medicines for veterinary purposes
Wadding for medical purposes
Pharmaceutical preparations for suppressing tumors.
The mark was filed in class 42 with following description of goods:
Pharmaceutical research services
Medical research
Biological research
Development of pharmaceutical preparations and medicines
Research in the field of artificial intelligence
Scientific investigations for medical purposes
Clinical trials
Medical research in the field of oncology
Bacteriological research
Biotechnology Research
Scientific research for medical purposes in the area of cancerous diseases